These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 16575686

  • 1. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.
    Zimmerhackl LB, Besbas N, Jungraithmayr T, van de Kar N, Karch H, Karpman D, Landau D, Loirat C, Proesmans W, Prüfer F, Rizzoni G, Taylor MC, European Study Group for Haemolytic Uraemic Syndromes and Related Disorders.
    Semin Thromb Hemost; 2006 Mar; 32(2):113-20. PubMed ID: 16575686
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
    Artz MA, Steenbergen EJ, Hoitsma AJ, Monnens LA, Wetzels JF.
    Transplantation; 2003 Sep 15; 76(5):821-6. PubMed ID: 14501861
    [Abstract] [Full Text] [Related]

  • 5. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.
    Ferraris JR, Ramirez JA, Ruiz S, Caletti MG, Vallejo G, Piantanida JJ, Araujo JL, Sojo ET.
    Pediatr Nephrol; 2002 Oct 15; 17(10):809-14. PubMed ID: 12376808
    [Abstract] [Full Text] [Related]

  • 6. [Hemolytic and uremic syndrome in the child].
    Niaudet P.
    Nephrol Ther; 2008 Feb 15; 4(1):34-40. PubMed ID: 17964233
    [Abstract] [Full Text] [Related]

  • 7. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C, French Society of Pediatric Nephrology.
    J Am Soc Nephrol; 2007 Aug 15; 18(8):2392-400. PubMed ID: 17599974
    [Abstract] [Full Text] [Related]

  • 8. Haemolytic uraemic syndrome: an overview.
    Amirlak I, Amirlak B.
    Nephrology (Carlton); 2006 Jun 15; 11(3):213-8. PubMed ID: 16756634
    [Abstract] [Full Text] [Related]

  • 9. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.
    Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship TH, Remuzzi G, International Registry of Recurrent and Familial HUS/TTP.
    Clin J Am Soc Nephrol; 2006 Jan 15; 1(1):88-99. PubMed ID: 17699195
    [Abstract] [Full Text] [Related]

  • 10. [Hemolytic-uremic syndrome].
    Bláhová K.
    Vnitr Lek; 2004 Jul 15; 50(7):519-25. PubMed ID: 15323259
    [Abstract] [Full Text] [Related]

  • 11. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
    Espié E, Grimont F, Mariani-Kurkdjian P, Bouvet P, Haeghebaert S, Filliol I, Loirat C, Decludt B, Minh NN, Vaillant V, de Valk H.
    Pediatr Infect Dis J; 2008 Jul 15; 27(7):595-601. PubMed ID: 18520972
    [Abstract] [Full Text] [Related]

  • 12. Graft failure due to hemolytic uremic syndrome recurrence.
    Iaria G, Iorio B, Anselmo A, De Luca L, Tariciotti L, Ielpo B, Muzi F, Lucchesi C, D'Andria D, Orlando G, Del Poeta G, Poggi E, Piazza A, Tisone G.
    Transplant Proc; 2006 May 15; 38(4):1020-1. PubMed ID: 16757250
    [Abstract] [Full Text] [Related]

  • 13. [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].
    Candinas D, Keusch G, Schlumpf R, Burger HR, Gmür J, Largiadèr F.
    Schweiz Med Wochenschr; 1994 Oct 15; 124(41):1789-99. PubMed ID: 7973505
    [Abstract] [Full Text] [Related]

  • 14. [Hemolytic uremic syndrome].
    Mele C, Noris M.
    G Ital Nefrol; 2007 Oct 15; 24(1):23-33. PubMed ID: 17342690
    [Abstract] [Full Text] [Related]

  • 15. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP.
    J Am Soc Nephrol; 2006 Jul 15; 17(7):2017-25. PubMed ID: 16762990
    [Abstract] [Full Text] [Related]

  • 16. Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor.
    Donne RL, Abbs I, Barany P, Elinder CG, Little M, Conlon P, Goodship TH.
    Am J Kidney Dis; 2002 Dec 15; 40(6):E22. PubMed ID: 12460067
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V, Bonucchi D, De Amicis S, Americo C, Ghiandai G, Cappelli G.
    Transplant Proc; 2010 May 15; 42(4):1352-4. PubMed ID: 20534299
    [Abstract] [Full Text] [Related]

  • 19. Hemolytic uremic syndrome in children.
    Talarico V, Aloe M, Monzani A, Miniero R, Bona G.
    Minerva Pediatr; 2016 Dec 15; 68(6):441-455. PubMed ID: 27768015
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.